These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 8470277)

  • 21. PG490-88, a new immunosuppressant, effectively prevents acute and chronic rejection in rat renal allografts.
    Pan F; Fisniku O; Wynn C; Erickson LM; Crews G; Jang MS; Sudo Y; Tamura K; Kobayashi M; Benediktsson H; Jiang H
    Transplant Proc; 2005; 37(1):134-6. PubMed ID: 15808572
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic mechanisms of alloantigen-dependent and independent events in chronic graft rejection.
    Tullius SG; Nieminen M; Qun Y; Egermann F; Reutzer-Selke A; Jonas S; Pratschke J; Bechstein WO; Volk HD; Neuhaus P
    Transplant Proc; 1998 Aug; 30(5):2411-2. PubMed ID: 9723521
    [No Abstract]   [Full Text] [Related]  

  • 23. The role of histoincompatibility in cardiac allograft vasculopathy.
    Costanzo MR
    J Heart Lung Transplant; 1995; 14(6 Pt 2):S180-4. PubMed ID: 8719482
    [No Abstract]   [Full Text] [Related]  

  • 24. Protocol core biopsy as intermediate efficacy end-point in chronic kidney allograft rejection.
    Yilmaz S; Taskinen E; Häyry P; Isoniemi H
    Transplant Proc; 1996 Feb; 28(1):491-3. PubMed ID: 8644324
    [No Abstract]   [Full Text] [Related]  

  • 25. Herpes virus infections, acute rejection, and transplant arteriosclerosis in human cardiac allografts.
    Jäkel KT; Löning T
    Transplant Proc; 1993 Apr; 25(2):2029-30. PubMed ID: 8385831
    [No Abstract]   [Full Text] [Related]  

  • 26. Is the malononitrilamide FK778 better for the prevention of acute or chronic rejection?
    Deuse T; Schrepfer S; Pelletier MP; Fischbein MP; Robbins RC; Reichenspurner H
    Transplant Proc; 2007 Mar; 39(2):569-72. PubMed ID: 17362784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantity of donor tissue and rat allograft survival.
    Sun J; Bishop G; Wang C; Wang L; McCaughan G; Sheil R
    Transplant Proc; 1997; 29(1-2):1143-4. PubMed ID: 9123240
    [No Abstract]   [Full Text] [Related]  

  • 28. Immune injury--is it all there is to chronic graft rejection?
    Fellström B
    Nephrol Dial Transplant; 1995; 10(2):149-51. PubMed ID: 7753443
    [No Abstract]   [Full Text] [Related]  

  • 29. Immune factors correlating with improved long-term graft outcome in kidney, lung, and heart transplants.
    Reinsmoen NL; Hertz MI; Kubo S; Bolman RM; Matas AJ
    Transplant Proc; 1993 Dec; 25(6):3277-8. PubMed ID: 8266541
    [No Abstract]   [Full Text] [Related]  

  • 30. Factors affecting early diagnosis of organ allograft rejection.
    Burdick JF; Kittur DS
    Transplant Proc; 1991 Aug; 23(4):2047-51. PubMed ID: 1871817
    [No Abstract]   [Full Text] [Related]  

  • 31. Evolution of chronic antibody mediated-rejection: a case report.
    Cornell LD; Wong W; Saidman S; Collins AB; Colvin RB
    Clin Transpl; 2006; ():463-7. PubMed ID: 18365404
    [No Abstract]   [Full Text] [Related]  

  • 32. Stereoscopic analysis of focal interstitial infiltrate in a model of chronic rejection.
    Stein-Oakley AN; Tzanidis A; Jablonski P; Baxter K; Marshall VC; Thomson NM
    Transplant Proc; 1992 Oct; 24(5):2284-5. PubMed ID: 1413058
    [No Abstract]   [Full Text] [Related]  

  • 33. Vascular and cellular mechanisms of chronic renal allograft dysfunction.
    Morris RE
    Transplantation; 2001 Jun; 71(11 Suppl):SS37-41. PubMed ID: 11583487
    [No Abstract]   [Full Text] [Related]  

  • 34. FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
    Rintala JM; Savikko J; Rintala SE; von Willebrand E
    Nephrol Dial Transplant; 2008 Nov; 23(11):3446-55. PubMed ID: 18558624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for chronic rejection in renal allograft recipients.
    Kim HC; Suk J; Joo I; Park SB; Park KK; Cho WH; Park CH
    Transplant Proc; 1996 Jun; 28(3):1456-7. PubMed ID: 8658739
    [No Abstract]   [Full Text] [Related]  

  • 36. Graft loss associated with late humoral rejection after renal transplantation.
    Sun Q; Li L
    Clin Transpl; 2006; ():521-5. PubMed ID: 18365417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection.
    Torrealba JR; Fernandez LA; Kanmaz T; Oberley TD; Schultz JM; Brunner KG; Peters D; Fechner JH; Dong Y; Hu H; Hamawy MM; Knechtle SJ
    Transplantation; 2003 Aug; 76(3):524-30. PubMed ID: 12923438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serial monitoring of humoral antibody-mediated rejection of cardiac allografts by C4d staining of interstitial capillaries.
    Suggs J; Goodin J; Cruse JM; Lewis RE; Allen B; Bigler S; Moore C; Thompson R; McIntire H
    Exp Mol Pathol; 2009 Feb; 86(1):41-5. PubMed ID: 19111538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synergistic effects of malononitrilamides (FK778, FK779) with tacrolimus (FK506) in prevention of acute heart and kidney allograft rejection and reversal of ongoing heart allograft rejection in the rat.
    Bilolo KK; Ouyang J; Wang X; Zhu S; Jiang W; Qi S; Xu D; Hebert MJ; Bekersky I; Fitzsimmons WE; Chen H
    Transplantation; 2003 Jun; 75(11):1881-7. PubMed ID: 12811249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic rejection of organ allografts may arise from injuries sustained in recurring foci of acute rejection that resolve spontaneously.
    Lowry RP; Takeuchi T; Cremisi H; Konieczny B; Someren A
    Transplant Proc; 1993 Apr; 25(2):2103-5. PubMed ID: 8470286
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.